Circio
Develops active immunotherapy in the form of cancer vaccines for application in post-operation treatments.
Launch date
Employees
Market cap
€2.4m
Enterprise valuation
(€12m) (Public information from Sep 2024)
Share price
NOK0.808 TRVX.OL
Company register number 996162095
Oslo Norway (HQ)
Authorizing premium user...